All Type of News
Pharmaceutical executive convicted
The Seoul Central District Court on Tuesday sentenced a 6-month jail term and 2-year suspension for a management official working at a pharmaceutical company on charges of giving 1.3 billion won to doctors for choosin...
Per capital medical bill highest in North Jeonnam Province
People residing Buan-gun, North Jeonnam Province spent per capita annual average of 1.8 million won on medical and healthcare services in 2010, a whopping 3-fold figure over 720,000 won in Suwon, Kyunggi Province, acc...
Daehwa wins patent for oral paclitaxel
Daehwa Pharmaceutical said Wednesday that the company won an U.S. patent covering the oral form of widely used cancer drug paclitaxel, which is normally administered through injection.
The patent covers "compositi...
KORUS FTA to take effect on March 15
Korea and the United States agreed to implement their free trade pact on March 15, six years after the two countries kicked off talks on the trade pact in June 2006.
Trade Minister Bark Tae-ho announced Tuesday tha...
KFDA to reclassify 500 medicines
The Korea Food & Drug Association (KFDA) said Tuesday that it has nearly completed the re-classification of all 6,630 drugs as part of measures to reduce customers' inconvenience in buying drugs and strengthen monitor...
Concerns growing over 24-hour large discount stores
As an increasing number of regions are trying to limit business hours at large discount stores and super supermarkets, pharmacists are attentively watching the situation.
Now that the National Assembly is likely to...
Foreign journals publish Amosartan
Hanmi’s anti-hypertension fixed-dose combination, Amosartan (amolodipine + Losartan), was published in international peer-reviewed journals, such as BMC (BioMed Central Research Notes) and AJCD (American Journal of Ca...
AstraZeneca Korea names Koo H.W. new medical head
Koo He-won was named the new medical head of AstraZeneca Korea.
Koo, 43, will be primarily responsible for scientific affairs and local clinical trials.
Koo, a graduate of Inje University’s medical college, obta...
Assembly likely to pass OTC drug sales bill
The ruling and opposition lawmakers agreed to extend the current extraordinary session until March 16 to deal with bills left unattended at each standing committee.
Among them is an OTC drug sales bill, which the N...
Dong-A hikes R&D budget in 2010
Dong-A Pharmaceutical Co., Korea’s No.1 pharmaceutical firm, said it spent 8 percent of its revenue on research and development (R&D) last year, up 0.6 percentage points from R&D budget in 2010.
“The increasing inv...
